Crizotinib neuroblastoma study 'very promising' Nursing Times Researchers at The Institute of Cancer Research in London used crizotinib with mTOR inhibitors to overcome the resistance of cancer cells, the paper published in the journal Cancer Cell revealed. Early experience of crizotinib in the US, where it has ... Dual drug therapy offers hope for deadly childhood cancer |
